leisure time -WSS

leisure time

author：hotspot 2025-09-06 03:40:43 - browse：8

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Wikipedia

WSS

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Microsoft strikes partnership with Duke Health to advance health AI

Nonprofit, backed by Microsoft, to certify AI tools in health care

Microsoft strikes partnership with Duke Health to advance health AI

Dramatically reducing cancer deaths requires the PASTEUR Act

Medicare Advantage coverage denials need scrutiny, senators say

focus

leisure time

knowledge

New air purifier tech could be key to improving indoor air quality

Study suggests new cause of Down syndrome: cells linked to aging

How one medical school became remarkably diverse

ER docs worry over extreme heat as a 'mass casualty event'

What does generative AI mean for health care? We asked experts

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Affirmative action in medical school literally saved lives

My superpower is killing ticks

Guidelines to prevent youth baseball injuries need more muscle

Merck to acquire Harpoon Therapeutics for $680 million

focus

At JPM 2024, hospital systems pitch financial strength to investors

Verily hires former Apple Health leader as chief scientific officer

For BCIs, commercial hurdles may be bigger than scientific ones

Gene therapy denied for Afghan refugee whose father aided U.S.

Gene therapy denied for Afghan refugee whose father aided U.S.

Gene therapy denied for Afghan refugee whose father aided U.S.

Wikipedia

leisure time

Wikipedia

entertainment